FY2013 CSR Website CSR > Site Reports > ZEON Group (Japan) > ZEON Medical Inc.

ZEON Medical Inc. was established in 1989 to continue ZEON Corporation's
medical business as its wholly owned subsidiary.
Since then the company has developed medical equipment that uses newmaterials, particularly biocompatible materials, produced by combining ZEON'svarious proprietary technologies. ZEON Medical acquired approval to manufacture
supplementary artificial hearts from the Ministry of Health and Welfare (now Ministryof Health, Labour and Welfare) in January 1990. This was a world-first technology atPresident Muneki Sawa

the time and a typical example of the company's success in this field.
In January 1990, ZEON Medical commenced operations to market its
supplementary artificial heart. In July 1996, it took over operation of exports,
research and development, and manufacturing divisions from ZEON Corporation,
the final addition in ZEON Medical's becoming a fully integrated medical equipment
business in both name and substance. Since then the company has developed,
manufactured, and marketed predominantly cardiovascular and gastrointestinal

ZEON Medical's research center and plant

medical equipment in an effort to expand its business domain as a domestic
manufacturer in Japan.
The healthcare field has been evolving dramatically in the wake of continuing advances in medical technologies.
With the sense of responsibility and purpose that comes with being stewards of health, we are continuing to develop
and improve our innovative medical equipment, and provide systems and services that satisfy our customers.
We will continue to deliver safe, high-quality products that can be used with peace of mind by doctors,
technologists, nurses, and other healthcare practitioners to maintain the well-being of their patients.
The research lab is within the Takaoka Plant. From the design stage, the researchlab works together with the manufacturing department and partakes in development
aimed at devising design and assembly methods that ensure efficient production
and consistent quality.

-1-FY2013 CSR Website CSR > Site Reports > ZEON Group (Japan) > ZEON Medical Inc.

1. Efforts to Reduce Environmental Impact
We monitor our environmental impact on an ongoing basis by setting emission reduction targets for chemicalsubstances subject to the PRTR Law and keeping track of the material balance of waste substances. In the comingyears we will implement strategies to reduce emission amounts.
In fiscal 2012, we consumed 1,530,343kWh of electric power, an increase from the fiscal 2011 level of
1,308,539kWh. Although we are implementing measures to reduce our power usage, we believe the level increased
owing to the establishment of a new research lab.
Efforts to reduce waste and design more environmentally friendly products include using less product packing
material and reducing part counts through integral casting.
To safeguard the safety of our employees, we conduct evacuation drills based on major earthquake and tsunami
scenarios, in addition to daily 4RKY *1 and near-miss prevention activities *2.
*1 4RKY
A risk assessment method whereby employees proactively eliminate risk by discussing and learning from each other about potent ial risk factors in their work environment andtasks as well as the circumstance those factors can create. The program consists of four steps, or rounds (R), hence the name 4RKY (KY is for “kiken yochi,” or risk assessment).
*2 Near-miss incidents
Near-miss incidents are unplanned events that nearly result in an accident, injury, or other loss.

2. Environmental Data
ZEON Medical Inc.
Substances
covered by PRTR
law

FY2008FY2009FY2010FY2011FY2012

Number of substances

11

1

1

1

Consumption (tons)

1.1

1.5

2.3

2.2

1.6

1.1

1.5

2.3

2.2

1.6

5.0

5.4

7.6

22

10

5.0

5.3

7.6

11

5.0

---

12

14.3

1,000

969

970

969

1,143

412

472

462

431

511

Amount emitted (tons)
Amount generated (before volumereduction) (tons)
Industrial waste
Amount sent to landfill (tons)
Water resources (Industrial water + Ground water +3Waterworks) consumption (1,000 m )CO2 emissions (tons)
Energy consumption (crude oil equivalent, kL)

One activity undertaken by the ZEON Takaoka Group is participation in neighborhood clean-up efforts along thenearby Kokubun-hama shoreline and the Himi Coast.
Also, to contribute to the development of the medical device industry in Toyama Prefecture as an administrative
member of the West Toyama Prefecture Medical Device Development Council, we conducted a business matching
program in which we spoke with local Hokuriku companies and followed up with individual meetings to examine
business opportunities.
In R&D, we participated in a research meeting held by the Toyama Industrial Technology Center and are moving
forward with development in collaboration with local companies.

-2-